Vesicostomy revisited: The best treatment for the hostile bladder in myelodysplastic children?

BJU International

Volumn 96, Issue 3, 2005, Pages 397-400

  Morrisroe, Shelby N ^a   O'Connor, R Corey ^a   Nanigian, Dana K ^a   Kurzrock, Eric A ^a   Stone, Anthony R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Myelodysplasia; Treatment outcome; Vesicostomy

Indexed keywords

ARTICLE; BLADDER FUNCTION; BLADDER STONE; CHILD; CLINICAL ARTICLE; CYSTOSTOMY; FEMALE; FOLLOW UP; HUMAN; HYDRONEPHROSIS; INFANT; KIDNEY FUNCTION; MALE; MYELODYSPLASIA; NEUROGENIC BLADDER; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECURRENT INFECTION; SPINA BIFIDA; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY DIVERSION; URINARY TRACT INFECTION; UROLOGIC SURGERY; VESICOURETERAL REFLUX;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTOSTOMY; FEMALE; HUMANS; HYDRONEPHROSIS; INFANT; MALE; RETROSPECTIVE STUDIES; SPINAL DYSRAPHISM; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS; VESICO-URETERAL REFLUX;

EID: 23244434606     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05638.x     Document Type: Article

References (17)

1. Bauer SB. Neurogenic dysfunction of the lower urinary tract in children. In Walsh PC, Retik AB, Vaughan ED, Wein AJ eds, Campbell's Urology, Vol. 3 Chapter 65, 8th edn. Philadelphia: WB Saunders Co, 1998: 2019-53
2. Smith ED. Urinary prognosis in spina bifida. J Urol 1972; 108: 815-7
3. Kaefer M, Pabby A, Barbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 1999; 162: 1068
4. Tarcan T, Bauer S, Olmedo E, Khoshbin S, Kelly M, Darbey M. Long-term follow-up of newborns with myelodysplasia and normal urodynamic findings: Is follow-up necessary. J Urol 2001; 165: 564
5. Edelstein RA, Bauer SB, Kelly MD et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995; 154: 1500-4
6. Tanaka H, Kakizaki H, Kobayashi S, Shibata T, Ameda K, Koyanagi T. The relevance of urethral resistance in children with myelodysplasia: its impact on the upper urinary tract deterioration an the outcome of conservative management. J Urol 1999; 161: 929-32
7. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelomeningocele patients. J Urol 1981; 126: 205-9
8. Blocksom BH Jr. Bladder pouch for tubeless cystostomy. J Urol 1957; 78: 398-401
9. Duckett JW Jr. Cutaneous vesicostomy in childhood: The Blocksom technique. Urol Clin North Am 1974; 1: 485-95
10. Michie AJ, Borns P, Ames MD. Improvement following tubeless suprapubic cystostomy of myelomeningocele patients with hydronephrosis and recurrent acute pyelonephritis. J Pediat Surg 1966; 1: 347-52
11. Noe NH, Jerkins GR. Cutaneous vesicostomy experience in infants and children. J Urol 1985; 134: 301-3
12. Cohen JS, Harback LB, Kaplan GW. Cutaneous vesicostomy for temporary urinary diversion in infants with neurogenic bladder dysfunction. J Urol 1978; 119: 120-1
13. Sonda LP, Solomon MH. Twenty-year outcome of cutaneous vesicostomy. J Urol 1980; 124: 326-8
14. Allen TD. Vesicostomy for the temporary diversion of the urine in small children. J Urol 1980; 123: 929-31
15. Mandell J, Bauer SB, Colodny AH, Retik AB. Cutaneous vesicostomy in infancy. J Urol 1981; 126: 92-3
16. Bruce RR, Gonzales ET. Cutaneous vesicostomy: a useful form of temporary diversion in children. J Urol 1980; 123: 927-8
17. Hutcheson JC, Cooper CS, Canning DA, Zderic SA, Snyder HM III The use of vesicostomy as permanent urinary diversion in the child with myelomeningocele. J Urol 2001; 166: 2351-3